Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mirja, Heikkinen"'
Autor:
Olli Nenonen, Hannu Nykänen, Jari T. Huttunen, Tero Väisänen, Seppo Hellsten, Pertti J. Martikainen, Mirja Heikkinen
Publikováno v:
Plant and Soil. 242:137-146
Concentrations of carbon dioxide (CO2), methane (CH4) and nitrous oxide (N2O) in the water column and their exchange at the water/air interface were studied during the open water period in two freshwater ponds with different catchment characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16570333590f40fe3f5d015d43c34fc0
https://doi.org/10.1023/a:1019606410655
https://doi.org/10.1023/a:1019606410655
Autor:
Pivi Hietanen, Heikki Joensuu, Kaija Holli, Mirja Heikkinen, Riikka Huovinen, Eero Suonio, Aria R. Aro
Publikováno v:
Europe PubMed Central
PURPOSE We report results of a randomized prospective study that compared single agents of low toxicity given both as the first-line and second-line chemotherapy with combination chemotherapy in advanced breast cancer with distant metastases. PATIENT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d973f8aeb5d45d6521cc793bd023b0a0
https://doi.org/10.1200/jco.1998.16.12.3720
https://doi.org/10.1200/jco.1998.16.12.3720
Autor:
Pirkko, Kellokumpu-Lehtinen, Tuija, Tuunanen, Raija, Asola, Liisa, Elomaa, Mirja, Heikkinen, Riitta, Kokko, Ritva, Järvenpää, Ilari, Lehtinen, Abdel, Maiche, Jaana, Kaleva-Kerola, Mauri, Huusko, Kari, Möykkynen, Timo, Ala-Luhtala
Publikováno v:
Anticancer research. 33(6)
Weekly paclitaxel is widely used in the treatment of metastatic breast cancer (MBC). Our aim was to test its efficacy and tolerability as a second-line therapy for MBC in daily oncology practice.Paclitaxel (90 mg/m(2)) was given intravenously three t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07cab43881e7fbcc4fc20ea60f22fd88
https://pubmed.ncbi.nlm.nih.gov/23749918
https://pubmed.ncbi.nlm.nih.gov/23749918
Autor:
Bengt Sorbe, H�kan Andersson, Margareta Schmidt, Martin S�derberg, Thomas H�gberg, Lars Wernstedt, Eva Tiensuu Janson, Bengt Ehrnstr�m, Mogens Kjaer, Hanne Havsteen, Maria Overgaard, Erik Sandberg, Martti Flander, Mirja Heikkinen, V�in�m� Nikkanen
Publikováno v:
Supportive Care in Cancer. 2:393-399
An open, noncomparative, Nordic multicenter study was carried out during 1991-1992 to evaluate the 5-HT3 receptor antagonist tropisetron (Navoban) as an antiemetic agent for various types of cancer chemotherapy. A total of 630 patients were recruited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85fd583e03fcebb73d8e950fd326d361
https://doi.org/10.1007/bf00344055
https://doi.org/10.1007/bf00344055
Autor:
Tapio A. Kuoppala, Lase Teerenhovi, Ismo T. Jantunen, Mirja Heikkinen, Vesa Kataja, Martti K. Flander
Publikováno v:
Acta oncologica (Stockholm, Sweden). 32(4)
One hundred cancer patients receiving non-cisplatin containing chemotherapy were entered in a prospective study in which the efficacy of ondansetron was compared with standard antiemetic treatments in the prophylaxis of nausea and emesis. During the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::814edb7409d3c267f7374b5d0e86037e
https://pubmed.ncbi.nlm.nih.gov/8369129
https://pubmed.ncbi.nlm.nih.gov/8369129
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ossi V. Lindqvist, Jari T. Huttunen, Olli Nenonen, Seppo Hellsten, Hannu Nykänen, Markku O. Virtanen, Arto Niskanen, Högne Jungner, Pertti J. Martikainen, Mirja Heikkinen, Tero Väisänen
Publikováno v:
Global Biogeochemical Cycles. 16:3-1
[1] Concentrations and fluxes of greenhouse gases methane (CH4), carbon dioxide (CO2), and nitrous oxide (N2O) were measured during open water conditions in two hydroelectric reservoirs, Lokka and Porttipahta, in the northern boreal zone in Finland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85633a15d2a4ef4fec8c5b8b1438e54d
https://doi.org/10.1029/2000gb001316
https://doi.org/10.1029/2000gb001316
Autor:
Erik Grönbæk, Jeremy C. Ganz, Karl Fr. Lindegaard, Olav Mella, Jens Haase, Bengt Rosengren, Matti Mäntylä, Leif Johansson, Ansgar Torvik, Ingrid Matheson, Bo Spännare, Stig Nyström, Per Sehested, Jorgen Rygård, Nils-Erik Säterborg, Sten Lindgren, Kristian Kristiansen, Mirja Heikkinen, Oddur Arnasson, Henning Busch, Steen Midholm, Anne Kiil Berthelsen, Rolf Ringkjöb, Arne Brun, Marck Lipecki, Eiler Lambrethsen, Gustav Notter, Stephen T. De Garis, Reidulv Hatlevoll, Bo Littbrand, Rud Hammer Jensen, Kjell Elgen, Steinar Hagen, Ragnar Nesbakken, Pentti Taskinen, Gudmundur Benediktsson, Ove Aaskoven
Publikováno v:
Cancer. 56:41-47
A prospective and randomized trial has been performed in order to evaluate combined modality therapy in patients with astrocytomas grade 3 and 4. Follow-up information is available on 244 patients. One half of the series received radiation therapy tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1254f4fcd652c079ecac5bfce630ab54
https://doi.org/10.1002/1097-0142(19850701)56:1<41::aid-cncr2820560108>3.0.co
https://doi.org/10.1002/1097-0142(19850701)56:1<41::aid-cncr2820560108>3.0.co
Publikováno v:
The Lancet. 312:946-947
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51fb2f3fbe598437263a6648a7b1e4ad
https://doi.org/10.1016/s0140-6736(78)91668-9
https://doi.org/10.1016/s0140-6736(78)91668-9